Package 50242-070-01
Brand: gazyva
Generic: obinutuzumabPackage Facts
Identity
Package NDC
50242-070-01
Digits Only
5024207001
Product NDC
50242-070
Description
1 VIAL, SINGLE-USE in 1 CARTON (50242-070-01) / 40 mL in 1 VIAL, SINGLE-USE
Marketing
Marketing Status
Brand
gazyva
Generic
obinutuzumab
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "47afa519-4a05-4ac2-8604-437371837128", "openfda": {"nui": ["N0000175078", "N0000175657"], "unii": ["O43472U9X8"], "rxcui": ["1442693", "1442698"], "spl_set_id": ["df12ceb2-5b4b-4ab5-a317-2a36bf2a3cda"], "pharm_class_epc": ["CD20-directed Cytolytic Antibody [EPC]"], "pharm_class_moa": ["CD20-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-070-01) / 40 mL in 1 VIAL, SINGLE-USE", "package_ndc": "50242-070-01", "marketing_start_date": "20131101"}, {"sample": true, "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-070-86) / 40 mL in 1 VIAL, SINGLE-USE", "package_ndc": "50242-070-86", "marketing_start_date": "20131104"}], "brand_name": "Gazyva", "product_id": "50242-070_47afa519-4a05-4ac2-8604-437371837128", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["CD20-directed Antibody Interactions [MoA]", "CD20-directed Cytolytic Antibody [EPC]"], "product_ndc": "50242-070", "generic_name": "obinutuzumab", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gazyva", "active_ingredients": [{"name": "OBINUTUZUMAB", "strength": "1000 mg/40mL"}], "application_number": "BLA125486", "marketing_category": "BLA", "marketing_start_date": "20131101", "listing_expiration_date": "20261231"}